Cutchins walks through a possible link between GLP-1 receptors and mast cell stabilization, and where insulin resistance and blood sugar swings fit in.
Recap by typeshit. Post by @manhattanpainmed on Instagram.
Topol points to work suggesting the body's own GLP-1 family peptides help reduce inflammation in the gut. Details are thin, so tap through for the study.
Medscape explores whether GLP-1 medicines might help keep people with schizophrenia out of the hospital. Tap through for the evidence behind the idea.
The weight loss drug class started with a lizard. A short local feature looks at how the Gila monster led researchers to GLP-1 medicines.
Healio
At the Cardiometabolic Health Congress, the UAB professor asked whether maximal weight loss is optimal and flagged that most non-diabetic patients quit GLP-1s within two years.
Emory's Angela Haynes-Ferere, who takes a GLP-1 herself, and Cedars-Sinai's Amanda Velazquez explain why weight loss stalls and why stopping the drug isn't the answer.
The trial tested three paths after initial weight loss: staying on the top tolerated dose, stepping down to 5 mg, or stopping and switching to another option.
Loading…